SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 100,600
+400 (0.40%)
At close: Aug 14, 2025, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.88 trillion as of August 14, 2025. Its market cap has increased by 22.98% in one year.
Market Cap
7.88T
Enterprise Value
7.76T
Revenue
578.00B
Ranking
n/a
PE Ratio
31.36
Stock Price
100,600.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.88T, a decrease of -20.79%. That is a compound annual growth rate of -4.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 7,846.99B | -9.81% |
| Dec 30, 2024 | 8,700.60B | 10.66% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.80T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,487.38B |
| Peptron | 8,130.78B |
| PharmaResearch | 6,909.12B |
| LigaChem Biosciences | 5,666.20B |
| HLB Co., Ltd. | 5,476.74B |